Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 31 papers were listed this time. Here's a few in our areas of research interest:
Kularatna S, Whitty JA, Johnson NW, et al. Health state valuation in low- and middle-income countries: a systematic review of the literature. Value Health. 2013 Sep-Oct;16(6):1091-9. Epub 2013 Jul 16. PubMed PMID: 24041360.
Chhatwal J, Ferrante SA, Brass C, et al. Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States. Value Health. 2013 Sep-Oct;16(6):973-86. PubMed PMID: 24041347.
Naylor RN, John PM, Winn AN, et al. The Cost-Effectiveness of Maturity-Onset Diabetes of the Young Genetic Testing - Translating Genomic Advances into Practical Health Applications. Diabetes Care. 2013 Sep 11. [Epub ahead of print] PubMed PMID: 24026547.
Blázquez-Pérez A, San Miguel R, Mar J. Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients. Pharmacoeconomics. 2013 Sep 3. [Epub ahead of print] PubMed PMID: 24000086.
